Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Kline

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Leukemia & Lymphoma|February 24, 2009
Will changing the face of WT1 make it more attractive to T cells?Justin Kline
Haematologica|March 16, 2023
The lymphoma microenvironment comes of age in the R-CHOP era?Alan Cooper, Justin Kline
Journal for Immunotherapy of Cancer|December 20, 2013
Immune evasion in acute myeloid leukemia: current concepts and future directionsRyan M Teague, Justin Kline
Expert Opinion on Pharmacotherapy|August 24, 2006
Nelarabine in the treatment of refractory T-cell malignant diseasesJustin Kline, Richard A Larson
Journal for Immunotherapy of Cancer|July 23, 2015
Update on checkpoint blockade therapy for lymphomaJustin Kline, Michael R Bishop
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancerJustin Kline, Thomas F Gajewski
Advances in Immunology|November 23, 2023
MHC cross-dressing in antigen presentationBrendan W MacNabb, Justin Kline
Frontiers in Oncology|April 28, 2015
Targeting the innate immune system as immunotherapy for acute myeloid leukemiaEmily Curran, Leticia Corrales, Justin Kline
Blood|May 7, 2009
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia modelLong Zhang, Thomas F Gajewski, Justin Kline
Cell Research|April 27, 2016
MYC - a thorn in the side of cancer immunityStefani Spranger, Thomas F Gajewski, Justin Kline
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|February 24, 2009
Will changing the face of WT1 make it more attractive to T cells?Justin Kline
Haematologica|March 16, 2023
The lymphoma microenvironment comes of age in the R-CHOP era?Alan Cooper, Justin Kline
Journal for Immunotherapy of Cancer|December 20, 2013
Immune evasion in acute myeloid leukemia: current concepts and future directionsRyan M Teague, Justin Kline
Expert Opinion on Pharmacotherapy|August 24, 2006
Nelarabine in the treatment of refractory T-cell malignant diseasesJustin Kline, Richard A Larson
Journal for Immunotherapy of Cancer|July 23, 2015
Update on checkpoint blockade therapy for lymphomaJustin Kline, Michael R Bishop
Current Opinion in Investigational Drugs (London, England : 2000)|December 15, 2010
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancerJustin Kline, Thomas F Gajewski
Advances in Immunology|November 23, 2023
MHC cross-dressing in antigen presentationBrendan W MacNabb, Justin Kline
Frontiers in Oncology|April 28, 2015
Targeting the innate immune system as immunotherapy for acute myeloid leukemiaEmily Curran, Leticia Corrales, Justin Kline
Blood|May 7, 2009
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia modelLong Zhang, Thomas F Gajewski, Justin Kline
Cell Research|April 27, 2016
MYC - a thorn in the side of cancer immunityStefani Spranger, Thomas F Gajewski, Justin Kline
Pageof 10